过去一年中添加的文章，按日期排序

The lethal M triad of myocarditis, myositis, and myasthenia gravis post immune checkpoint inhibitors therapy: A systematic review

A Qdaisat, D Lipe, P Krishnamani, TD Nguyen… - The Journal of …, 2024 - Elsevier
39 天前 - … -checkpoint inhibitor (ICI) therapy. However, these therapies are accompa- nied by
multiple unique immune-related adverse effects … the characteristics of cancer patients with no …
相关文章 所有 2 个版本
[PDF] bmj.com

P140 Investigating circulating miRNAs as diagnostic and prognostic biomarkers of immune checkpoint inhibitor-related colitis

M Swaminathan, A Olsson-Brown, J Sacco… - Gut, 2024 - gut.bmj.com
39 天前 - … Immune checkpoint inhibitors (ICIs) such as PD1, PD-L1, and CTLA-4 inhibitors
that are used in cancer treatment … toxicities known as immune-related adverse events (irAEs). …
相关文章

Characteristics and disposition of cancer patients presenting to the emergency department with low ACTH and cortisol levels after immunotherapy

H Fatima, A Qdaisat, SCJ Yeung - The Journal of Emergency Medicine, 2024 - Elsevier
39 天前 - … -checkpoint inhibitor (ICI) therapy. However, these therapies are accompanied by
multiple unique immune-related adverse effects … the characteristics of cancer patients with no …
相关文章 所有 2 个版本
[PDF] bmj.com

… -POSITIVITY BEFORE TREATMENT IS ASSOCIATED WITH IMMUNE-RELATED ADVERSE EVENTS IN MELANOMA PATIENTS TREATED WITH ANTI-PD-1

TJ Van Wesemael, JSW Borgers, KA Gelderman… - 2024 - ard.bmj.com
39 天前 - … , PD-1 inhibition may also activate auto-reactive T-cells leading to immune-related
adverse events (… Autoantibodies might also play a role in anti-PD-1 induced irAEs and could …
相关文章
[PDF] bmj.com

P121 Vedolizumab for the treatment of steroid refractory, infliximab non-responsive immune checkpoint inhibitor colitis

MU Khan, B Lee, PC Hawker - 2024 - gut.bmj.com
39 天前 - … (ICI) have revolutionized the treatment landscape for oncology producing durable …
inflammatory adverse events collectively referred to as immune-related adverse events. …
相关文章
[PDF] bmj.com

… MYOCARDITIS AND MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) IN PATIENTS WITH MELANOMA RECEIVING IMMUNE CHECKPOINT INHIBITORS

M Suarez-Almazor, J Ruiz, B Zhao, N Palaskas… - 2024 - ard.bmj.com
39 天前 - … immune and inflammatory pathways. While cardiovascular (CV) immune-related
adverse events … identified, less is known about other potential CV effects of ICI [1]. Given the …
相关文章
[PDF] bmj.com

… ADVERSE EVENTS IN PATIENTS WITH A PRE-EXISTING AUTOIMMUNE OR INFLAMMATORY DISEASE TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A …

X Jannot, N Sedmak, E Sauleau, J Sibilia… - 2024 - ard.bmj.com
39 天前 - … SNDS]) who initiated any immune checkpoint inhibitor (ICI) therapy for any …
immune-related adverse events (irAEs) during ICI treatment and in the 12 months post-administration…
相关文章
[PDF] bmj.com

… DISTINCT IMAGING PHENOTYPE IN PATIENTS WITH ARTHRALGIA OR INFLAMMATORY ARTHRITIS AFTER EXPOSURE TO IMMUNE CHECKPOINT INHIBITORS

K Harnden, N Sidhu, E Rowbotham, S Sharrack… - 2024 - ard.bmj.com
39 天前 - … Background: Immune checkpoint inhibitors (ICIs) have revolutionised cancer
treatment. However, immune related adverse events are common and a persistent inflammatory …
相关文章
[PDF] bmj.com

POS0715 TREATMENT PATTERNS OF IMMUNE CHECKPOINT INHIBITOR (ICI) INDUCED ARTHRITIS AND PMR AT THE RHEUMATOLOGY CLINIC AT …

M Liapi, K Chatzidionysiou - 2024 - ard.bmj.com
39 天前 - … treatment strategy for the treatment of rheumatological immune-related adverse
events (r-irAEs) induced by cancer immunotherapy with immune-checkpoint inhibitors (ICIs) is …
相关文章

112P The presence of liver metastases does not predict resistance to immunotherapy in proficient MMR metastatic colorectal cancer (mCRC): A secondary analysis of …

M Carullo, C Antoniotti, D Rossini… - Annals of …, 2024 - annalsofoncology.org
39 天前 - … an immune-suppressive tumor microenvironment and are associated with poor
efficacy of immune checkpoint inhibitor … No differences in terms of immune-related features were …
相关文章